Pentobarbital Sodium

CHEMBL971 Phase 4 Zugelassen Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
248.2 g/mol
LogP
Phase
4

A sodium salt form of pentobarbital with the same therapeutic properties. This barbiturate treats severe seizures and is used for sedation before surgery.

Molekularmasse

248,2500 g/mol

TPSA

81,60 Ų

Therapeutische Bereiche

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCC(C)C1(CC)C(=O)N=C([O-])NC1=O.[Na+]

InChI

InChI=1S/C11H18N2O3.Na/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15;/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16);/q;+1/p-1

Molecular Formula

C11H17N2NaO3

HBD / HBA

1 / 3

Rotierbare Bindungen

4

Schwere Atome

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

A sodium salt form of pentobarbital with the same therapeutic properties. This barbiturate treats severe seizures and is used for sedation before surgery.

Yes, Pentobarbital Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL971. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 23676152. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.